Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy
There are limited and discrepant data on prostate cancer (PCa) and vitamin D. We investigated changes in three vitamin D<sub>3</sub> metabolites in PCa patients after prostatectomy with zoledronic acid (ZA) treatment regarding their metastasis statuses over four years. In 32 patients fro...
Main Authors: | Carsten Stephan, Bernhard Ralla, Florian Bonn, Max Diesner, Michael Lein, Klaus Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/6/1560 |
Similar Items
-
An Update on Vitamin D Metabolism
by: Federica Saponaro, et al.
Published: (2020-09-01) -
Vitamin D—The Iceberg in Endometriosis—Review and Meta-Analysis
by: Alexandra Ursache, et al.
Published: (2024-01-01) -
Effects of Phototherapy on Free Vitamin D Levels in Ten Patients with Atopic Dermatitis
by: Andrea Elmelid, et al.
Published: (2022-12-01) -
Vitamin D Status in Bipolar Disorder
by: Zita Späth, et al.
Published: (2023-11-01) -
HYGIENIC VALUE OF VITAMIN D DEFICIENCY IN IRKUTSK REGION AND WAYS OF ITS PREVENTION
by: T. A. Spasich, et al.
Published: (2014-11-01)